Quantamental Technologies LLC Fibrogen Inc Transaction History

Quantamental Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $101,473 - $165,628	12,780 New	12,780 $135,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $106,014 - $277,428	-10,414 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $193,387 - $371,571	10,414 New	10,414 $277,000
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $200,248 - $264,389	-5,399 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$40.47 - $45.5 $218,497 - $245,654	5,399 New	5,399 $222,000
Q2 2019 Aug 12, 2019	SELL	$35.13 - $55.53 $1,510 - $2,387	-43 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$42.83 - $59.91 $1,841 - $2,576	43 New	43 $2,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.